Phibro Animal Health | PAHC - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Align Technology USD 1.06B 35.07M 2026-03
ANI Pharmaceuticals USD 311.18M 25.59M 2026-03
Aurora Cannabis CAD 64.69M 8.33M 2026-03
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Canopy Growth CAD 364.68M 6.64M 2026-03
Corcept Therapeutics USD 111.04M 2.3M 2026-06
Eli Lilly USD 5.28B 1.99B 2026-03
Henry Schein USD 138M 18M 2026-03
Idexx Laboratories USD 200.53M 20.46M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Merck USD 5.33B 9.24B 2026-03
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Pacira USD 144.31M 14.24M 2026-03
Phibro Animal Health USD 54.93M 557K 2026-03
Prestige Brands USD 63.87M 1.5M 2026-03
Supernus Pharmaceuticals USD 184.87M 56.42M 2026-03
Zoetis USD 1.94B 369M 2026-03